Thus, there is an urgent need for a suitable Tardbp mouse model that can delve into the progression of Tdp-43 toxicity in specific developmental stages or tissue/cell types, which is vital for understanding ALS/FTD's pre- to post-symptomatic transition. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.